Featured Research

from universities, journals, and other organizations

US Health care: Massachusetts health-care reform increased access to care, particularly among disadvantaged

Date:
July 15, 2011
Source:
Harvard Medical School
Summary:
Researchers have found that Massachusetts health reform has effectively increased access to health care and reduced disparities.

Recent research conducted at Harvard Medical School and the Harvard School of Public Health may have strong implications for informing the controversial debate currently surrounding national health care reform.

In a study published in the July edition of the American Journal of Preventive Medicine, the Harvard research team, led by first author Aakanksha Pande, a doctoral student in the Department of Population Medicine at HMS and Harvard Pilgrim Health Care Institute, found that Massachusetts health reform has effectively increased access to health care and reduced disparities. Massachusetts health reform is structurally similar to the 2010 Patient Protection and Affordable Care Act (PPACA), the federal statute signed into law by President Obama last year.

"As the political rhetoric heats up in advance of another presidential election cycle," said senior author Joshua Salomon, associate professor of international health at HSPH, "it's important to understand what the experience in Massachusetts tells us about the effects of health reform on access and affordability of care."

The researchers found that three years after being enacted in 2006, Massachusetts health reform was associated with a 7.6 percent increase in health insurance among residents, 4.8 percent decrease in those forgoing health care due to cost, and 6.6 percent increase in residents having a primary care physician. They also found that these improvements were most evident among socioeconomically disadvantaged groups.

Does Massachusetts health reform provide a good proxy for national reform? "Yes and no," said Pande. The terms of each act are similar, including the provision of a health mandate that requires all residents to obtain health insurance. However, Massachusetts health reform was passed with very little opposition in the state legislature, whereas the PPACA has been met with contention. For this reason, implementing health reform at the national level might prove more difficult.

According to Salomon, the success of Massachusetts health reform cannot be ignored. "Our study confirms that there has been a dramatic rise in health care coverage in Massachusetts since health reform was passed," he said.

"There had been lots of discussion in the media about the political and ethical aspects of requiring health insurance," said Pande. "But evidence of whether or not a health mandate works had not been established in a rigorous manner. We approached the issue from a neutral perspective and determined that, in Massachusetts, it does."

This research was funded by the Harvard Medical School Fellowship in Pharmaceutical Policy Research and Harvard Pilgrim Health Care Institute, the Harvard University PhD Program in Health Policy, and a fellowship for students from India in honor of Amartya Sen, the Thomas W. Lamont Harvard University Professor] from the Graduate School of Arts and Sciences at Harvard.


Story Source:

The above story is based on materials provided by Harvard Medical School. The original article was written by Joanna Logue. Note: Materials may be edited for content and length.


Journal Reference:

  1. Aakanksha H. Pande, Dennis Ross-Degnan, Alan M. Zaslavsky, Joshua A. Salomon. Effects of Healthcare Reforms on Coverage, Access, and Disparities. American Journal of Preventive Medicine, 2011; 41 (1): 1 DOI: 10.1016/j.amepre.2011.03.010

Cite This Page:

Harvard Medical School. "US Health care: Massachusetts health-care reform increased access to care, particularly among disadvantaged." ScienceDaily. ScienceDaily, 15 July 2011. <www.sciencedaily.com/releases/2011/07/110715155155.htm>.
Harvard Medical School. (2011, July 15). US Health care: Massachusetts health-care reform increased access to care, particularly among disadvantaged. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/07/110715155155.htm
Harvard Medical School. "US Health care: Massachusetts health-care reform increased access to care, particularly among disadvantaged." ScienceDaily. www.sciencedaily.com/releases/2011/07/110715155155.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins